Medications to Control Airway Secretions: Mucolytics, Expectorants, and Anticholinergics

Medications that control airway secretions help thin thick mucus, reduce excess secretions, and improve airway clearance in patients with respiratory disease. This note reviews the major drug classes, their mechanisms, key indications, side effects, and the nursing priorities you need for the NCLEX.

Drug Class Quick Reference

Mechanism of Action

• Mucolytics break disulfide bonds in thick mucus, reducing mucus viscosity so secretions become thinner and easier to cough out.
• Expectorants increase hydration of respiratory secretions, improving mucus clearance.
• Anticholinergics block muscarinic receptors in airway glands, reducing mucus production.

Drug Class Overview

These medications reduce mucus obstruction and improve airway clearance, supporting better ventilation and oxygenation. They are commonly used in diseases associated with thick or excessive respiratory secretions.

High-yield clinical conditions include:

• Chronic obstructive pulmonary disease (COPD)
• Cystic fibrosis
• Bronchitis
• Pneumonia

Indications and Guideline Notes

Airway secretion medications are used for:

• Thick airway mucus
• Excess respiratory secretions
• Impaired airway clearance

Key guideline points:

• Respiratory care guidelines recommend mucolytic therapy in patients with thick secretions that impair ventilation.
• In cystic fibrosis, mucolytics improve mucus clearance and lung function.
• These medications should be combined with:
  • Adequate hydration
  • Chest physiotherapy
  • Airway suctioning when needed

Side Effects

Common side effects:

• Nausea
• Vomiting
• Throat irritation

Class-specific effects:

• Acetylcysteine can cause bronchospasm and coughing.
• Anticholinergics cause dry mouth, blurred vision, and urinary retention.

Monitoring and Assessment

Monitor patients receiving these medications for:

• Respiratory status
• Ability to clear secretions
• Oxygen saturation

Therapeutic response is shown by improved cough effectiveness and increased sputum clearance.

Contraindications

Use cautiously in patients with:

• Severe asthma
• Known hypersensitivity to the medication

Mucolytics can occasionally trigger bronchospasm in sensitive patients.

Special Considerations

• Adequate fluid intake helps thin respiratory secretions.
• Humidified oxygen or humidified air may improve mucus clearance.
• Airway suctioning may be required in patients unable to cough effectively.

Nursing Safety Rules and High-Yield NCLEX Notes

• Encourage patients to increase fluid intake to help loosen mucus.
• Teach airway clearance techniques: deep breathing, coughing, and chest physiotherapy.
• Patients should report increased wheezing or bronchospasm after mucolytic therapy.
• Acetylcysteine is both a mucolytic and the antidote for acetaminophen toxicity — a classic NCLEX point.

Key takeaways

• Mucolytics (acetylcysteine) break disulfide bonds to thin mucus; expectorants (guaifenesin) increase mucus clearance; anticholinergics (ipratropium) reduce secretion production.
• These drugs are most often used in COPD, cystic fibrosis, bronchitis, and pneumonia.
• Watch for bronchospasm with acetylcysteine, especially in patients with asthma.
• Anticholinergics cause classic anti-SLUD effects: dry mouth, blurred vision, urinary retention.
• Combine drug therapy with hydration, chest physiotherapy, and suctioning as needed.
• Remember: acetylcysteine is also the antidote for acetaminophen overdose.